Literature DB >> 21617590

Analysis of factors affecting recurrence of hepatocellular carcinoma after liver transplantation with a special focus on inflammation markers.

Valentina Rosa Bertuzzo1, Matteo Cescon, Matteo Ravaioli, Gian Luca Grazi, Giorgio Ercolani, Massimo Del Gaudio, Alessandro Cucchetti, Antonietta D'Errico-Grigioni, Rita Golfieri, Antonio Daniele Pinna.   

Abstract

BACKGROUND: Systemic inflammation markers, such as neutrophil-to-lymphocyte ratio (NLR), have recently emerged as the prognostic factors for recurrence of liver tumors.
METHODS: We assessed the ability of NLR and of other variables to predict the outcomes of orthotopic liver transplantation (OLT) for hepatocellular carcinoma (HCC). A retrospective analysis was performed in 219 patients with HCC who underwent OLT between 1997 and 2009, with a median follow-up of 40 months.
RESULTS: Overall 3- and 5-year patient survival rates were 76.6% and 70.7%, respectively. Overall 3- and 5-year recurrence-free survival (RFS) rates were 83.8% and 82.1%, respectively. On univariate analysis, the factors affecting overall survival were α-fetoprotein more than 30 ng/mL (P=0.006), NLR more than or equal to 5 (P<0.0001), hepatitis C infection (P=0.043), and presence of microvascular invasion (MVI; P=0.006). Preoperative treatments (P=0.006), α-fetoprotein more than 30 ng/mL (P=0.003), NLR more than or equal to 5 (P<0.0001), exceeding Milan criteria at final histology (P=0.001), poor tumor differentiation (P=0.02), and presence of MVI (P<0.0001) predicted a lower RFS. Cox's proportional hazard model showed that only increased NLR and presence of MVI independently predicted overall survival and RFS.
CONCLUSIONS: NLR is an important predictor of outcome after OLT for HCC and should be used to identify OLT candidates at high risk of recurrence.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21617590     DOI: 10.1097/TP.0b013e3182187cf0

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  45 in total

1.  Relationship of preoperative neutrophil lymphocyte ratio with prognosis in gastrointestinal stromal tumors.

Authors:  Süleyman Kargın; Murat Çakır; Ebubekir Gündeş; Yusuf Yavuz; Hacı Hasan Esen; M Sinan İyisoy; Naile Kökbudak; Tevfik Küçükkartallar
Journal:  Ulus Cerrahi Derg       Date:  2015-06-01

Review 2.  Liver transplantation for hepatocellular carcinoma: role of inflammatory and immunological state on recurrence and prognosis.

Authors:  Matteo Cescon; Valentina Rosa Bertuzzo; Giorgio Ercolani; Matteo Ravaioli; Federica Odaldi; Antonio Daniele Pinna
Journal:  World J Gastroenterol       Date:  2013-12-28       Impact factor: 5.742

3.  Liver transplantation: a simple inflammation marker predicts liver cancer prognosis.

Authors:  Zhao-You Tang
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-07-04       Impact factor: 46.802

Review 4.  Strategies to improve outcome of patients with hepatocellular carcinoma receiving a liver transplantation.

Authors:  Marta Guerrero-Misas; Manuel Rodríguez-Perálvarez; Manuel De la Mata
Journal:  World J Hepatol       Date:  2015-04-08

5.  Milan criteria and its expansions in liver transplantation for hepatocellular carcinoma.

Authors:  Zhijun Zhu
Journal:  Hepatobiliary Surg Nutr       Date:  2016-12       Impact factor: 7.293

Review 6.  Prediction of hepatocellular carcinoma biological behavior in patient selection for liver transplantation.

Authors:  Umberto Cillo; Tommaso Giuliani; Marina Polacco; Luz Maria Herrero Manley; Gino Crivellari; Alessandro Vitale
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

7.  Neutrophil-to-lymphocyte ratio acts as a prognostic factor for patients with advanced hepatocellular carcinoma.

Authors:  Xing Li; Zhan-Hong Chen; Xiao-Kun Ma; Jie Chen; Dong-Hao Wu; Qu Lin; Min Dong; Li Wei; Tian-Tian Wang; Dan-Yun Ruan; Ze-Xiao Lin; Yan-Fang Xing; Yun Deng; Xiang-Yuan Wu; Jin-Yun Wen
Journal:  Tumour Biol       Date:  2014-08-06

8.  Downstaging advanced hepatocellular carcinoma to the Milan criteria may provide a comparable outcome to conventional Milan criteria.

Authors:  Jianyong Lei; Wentao Wang; Lunan Yan
Journal:  J Gastrointest Surg       Date:  2013-05-30       Impact factor: 3.452

Review 9.  Liver transplantation for hepatobiliary malignancies: a new era of "Transplant Oncology" has begun.

Authors:  Taizo Hibi; Osamu Itano; Masahiro Shinoda; Yuko Kitagawa
Journal:  Surg Today       Date:  2016-04-29       Impact factor: 2.549

10.  Neutrophil-lymphocyte ratio predicts the prognosis of patients with hepatocellular carcinoma after liver transplantation.

Authors:  Guang-Qin Xiao; Chang Liu; Da-Li Liu; Jia-Yin Yang; Lu-Nan Yan
Journal:  World J Gastroenterol       Date:  2013-12-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.